Michelson Diagnostics launches new improved version of VivoSight OCT scanner with Micro-Camera to aid skin cancer diagnosis

Orpington, UK, 8th October 2014 – Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, announces the launch of a new improved version of its innovative VivoSight OCT scanner at the European Academy of Dermatology and Venereology (EADV) Annual Meeting, 8-12 October, Amsterdam.

The VivoSight scanner probe is now equipped with a new Micro Camera that provides the user with a real-time, colour, magnified view of the skin lesion being scanned. The new Micro Camera image is shown simultaneously with the vertical and en face OCT images, making the VivoSight scanner the only dermatological clinical OCT device to provide a threefold view of the lesion. The Micro Camera view can also be stored along with the OCT image data, for later review by the clinician.

Feedback from VivoSight OCT users who have already tested the new OCT probe has been very positive:

“[The patients] will really like it. It is the first diagnostic procedure they can understand, as they can see what is going on underneath the visible lesion” – Prof. Kurzen, Freising

“I know precisely where the scans are captured and can be assured of accurately targeting the lesion” – Dr Algermissen, Berlin

“This additional image is an unrivalled benefit for my orientation and medical decision making” – Dr Heckmann, Starnberg

Jon Holmes, CEO of Michelson Diagnostics, added “Our VivoSight OCT scanner is already proving popular with Dermatologists who are keen to deliver the best possible care to their non-melanoma skin cancer patients, and based on this initial feedback I am sure that the new improved probe with Micro-Camera will further accelerate the adoption of VivoSight OCT as a standard tool for the practising Dermatologist”.